NPI registry status
Active
2026 NPPES data Ophthalmic Plastic and Reconstructive Surgery Physician NPI 1174532527 MD
Verify on CMS → Scott Goldstein, MD
Ophthalmic Plastic and Reconstructive Surgery Physician in Southampton, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 303 in Ophthalmic Plastic and Reconstructive Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
489
Medicare Part D claims · 380 beneficiaries · Ophthalmic Plastic and Reconstructive Surgery Physician avg: 642
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$526.18
20 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Scott Goldstein, MD filed 489 Medicare Part D claims in 2024 as an Ophthalmic Plastic and Reconstructive Surgery Physician in Southampton, Pennsylvania, prescribing 91% generic.
- 489
- Part D claims, 2024
- 91%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Scott Goldstein, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1174532527), first enumerated 08/05/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 489 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
4 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$526.18 in reported industry payments (20 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Scott Goldstein, MD's individual license status. Verify directly with the state medical board.
Source: PA-BOM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Goldstein with other Ophthalmic Plastic and Reconstructive Surgery Physician providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in Pennsylvania
- Dr. Blair Armstrong, M.D. Langhorne, PA
- Dr. Lance Bodily, M.D. Pittsburgh, PA
- Dr. Daniel Buerger, MD Pittsburgh, PA
- Dr. David Buerger, MD Pittsburgh, PA
- Dr. Phillip Choo, M.D. Pittsburgh, PA
- Dr. Pavle Doroslovacki, MD Pittsburgh, PA
Other specialties in Southampton: Mental Health Counselor (23) · Speech-Language Pathologist (19) · Physical Therapist (19) · Professional Counselor (19)
CMS NPPES provider registry desk
NPI 1174532527 · Ophthalmic Plastic and Reconstructive Surgery Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1174532527
- ENUM-LEGACY 2006
- TAX-TRACE 303
- RX-LIGHT 489
- BOOK-THIN 16 in Pennsylvania
- PHOTO-ENUM L Freeman, MD · 2006
Scott Goldstein, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
489 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Scott Goldstein, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 4 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Scott Goldstein, MD?
Quality data not reportedPrimary specialty
Ophthalmic Plastic and Reconstructive Surgery Physician
Medicare Part D claims
489 24% vs specialty avg
Specialty distribution in Pennsylvania
How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ophthalmic Plastic and Reconstructive Surgery Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1174532527 |
|---|---|
| Specialty | Ophthalmic Plastic and Reconstructive Surgery Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/05/2006 |
Hospital and facility affiliations
Facilities where Scott Goldstein, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Scott Goldstein, MD is affiliated with 4 Medicare-billing facilities.
Bethlehem Eye Associates PC
Bethlehem, PA
Tri-Century Eye Care, P.C.
Southampton, PA
University OF Penn - Medical Group
Philadelphia, PA
Vision Innovation Centers OF Pennsylvania LLC
West Pittston, PA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Scott Goldstein, MD. Source: openpaymentsdata.cms.gov.
Total received
$526
Largest payer
REVANCE THERAPEUTICS, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Scott Goldstein, MD. To verify Scott Goldstein, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Scott Goldstein, MD - brand share 9.0%
Ophthalmic Plastic and Reconstructive Surgery Physician average
9% brand-name claims vs 91% generic, on 489 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
489
Total Claims
$18K
Total Drug Cost
380
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 519.533
- Total Day Supply
- 7,939
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $13K
- Generic Drug Cost
- $5K
- Antibiotic Claims
- 32
Patient Demographics
- Average Patient Age
- 75.7 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 11, 65-74: 168, 75-84: 151, 85+: 50
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Scott Goldstein, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Erythromycin
Erythromycin
269 claims
- Neomycin-Polymyxin… 105
Neomycin-Polymyxin-Dexameth
105 claims
- Doxycycline Hyclate 31
Doxycycline Hyclate
31 claims
- Prednisolone Acetate 17
Prednisolone Acetate
17 claims
- Triamcinolone Acet… 15
Triamcinolone Acetonide
15 claims
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 269 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 105 |
| Doxycycline Hyclate | 31 |
| Prednisolone Acetate | 17 |
| Triamcinolone Acetonide | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Ophthalmic Plastic and Reconstructive Surgery Physician in PA →
All providers in Pennsylvania →
Compare specialties →
Ophthalmic Plastic and Reconstructive Surgery Physician Overview
How Scott Goldstein, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.
303
Ophthalmic Plastic and Reconstructive Surgery Physician Providers in US
44
States with Ophthalmic Plastic and Reconstructive Surgery Physician
642
Avg Claims per Provider
Scott Goldstein, MD's 489 claims are below the specialty average of 642.
Nationwide Ophthalmic Plastic and Reconstructive Surgery Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Goldstein, both outside Pennsylvania so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Goldstein.
One of 16 Ophthalmic Plastic and Reconstructive Surgery Physician providers enrolled in Pennsylvania, 11 are shown on this page.
Frequently Asked Questions
What is Scott Goldstein, MD's specialty? ▼
Scott Goldstein, MD specializes in Ophthalmic Plastic and Reconstructive Surgery Physician and practices in Southampton, Pennsylvania. Credentials: MD.
How much does Scott Goldstein, MD prescribe under Medicare Part D? ▼
In 2024, Scott Goldstein, MD wrote 489 Medicare Part D claims totaling $18K in drug costs for 380 beneficiaries.
Where is Scott Goldstein, MD located? ▼
Scott Goldstein, MD is located at 319 2ND STREET PIKE, Southampton, PA, 18966. Phone: (215) 355-4428.
What is Scott Goldstein, MD's NPI number? ▼
Scott Goldstein, MD's National Provider Identifier (NPI) is 1174532527, issued on 08/05/2006.
Does Scott Goldstein, MD prescribe more brand-name or generic drugs? ▼
Scott Goldstein, MD's prescribing is 9% brand-name and 91% generic drugs by claim count, with $13K in brand drug costs.
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
There are 303 Ophthalmic Plastic and Reconstructive Surgery Physician providers across 44 states in the US. The average Ophthalmic Plastic and Reconstructive Surgery Physician provider writes 642 Medicare Part D claims per year.
What drugs does Scott Goldstein, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Scott Goldstein, MD's most frequently prescribed drugs include Erythromycin, Neomycin-Polymyxin-Dexameth, Doxycycline Hyclate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Scott Goldstein, MD accept Medicare? ▼
Scott Goldstein, MD appears in CMS Medicare data with 489 Part D claims and 380 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Scott Goldstein, MD's credentials? ▼
Scott Goldstein, MD's NPI is 1174532527 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.